Nieuws en video's - SPECTRUM GROUP INTL SPGZ

BC Centre on Substance Use hosts inaugural Cannabis Science Symposium PR Newswire VANCOUVER, Nov. 25, 2019 VANCOUVER , Nov. 25, 2019 /PRNewswire/ - Dr. M-J Milloy, the Canopy Growth Professor of Cannabis Science at the University of British Columbia ("UBC") is proud to bring together patients and other people with lived and living experience with researchers, clinicians, and policymakers for the inaugural Cannabis Science Symposium with the goal of establishing a research agenda for cannabis and...

INTERCURE: CANNDOC Initiates Phase 3 Clinical Trial Evaluating Pharma Grade Medicinal Cannabis (CANNDOC T1/C20) For Children With Autism Spectrum Disorder For years Canndoc has been successfully supplying medical cannabis-based products that providing efficient treatment for children diagnosed with autism spectrum disorder Canndoc's medicinal cannabis clinical pipeline includes 9 approved Phase 2 clinical trials PR Newswire HERZLIYA, Israel, Nov. 21, 2019 HERZLIYA, Israel , Nov. 21, 2019...

Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting PR Newswire VANCOUVER, Nov. 18, 2019 NASDAQ: CORV TSX: CORV Post Hoc Analysis of Subset of Patients Treated in the Emergency Department Setting Safety Outcomes of Interest Observed in Less Than 1% Cases; No Deaths Reported Greater Than 70% of Atrial Fibrillation Episodes Successfully Converted to Sinus Rhythm in a Median Time of 12 Minutes VANCOUVER , Nov. 18, 2019 /PRNewswire/...

Spectrum Therapeutics y Tree of Knowledge anuncian asociación para educar y apoyar a los profesionales de la salud PR Newswire SMITHS FALLS, Ontario, 30 de octubre de 2019 SMITHS FALLS, Ontario , 30 de octubre de 2019 /CNW/ - Spectrum Therapeutics, la división médica de Canopy Growth Corporation ("Canopy Growth") (TSX: WEED ) (NYSE: CGC), tiene el placer de anunciar su asociación con Tree of Knowledge International Corp. ("Tree of Knowledge") (CSE: TOKI) (OTC: TOKIF) para brindar educación...

Heliospectra to Provide Eco Canadian Organic Inc. With LED Spectrum Control for High-Quality Cannabis Production PR Newswire GOTHENBURG, Sweden and SAN FRANCISCO, Oct. 18, 2019 GOTHENBURG, Sweden and SAN FRANCISCO, Oct. 18, 2019 /PRNewswire/ -- Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH GROWTH MARKET: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from Eco Canadian Organic Inc. (E.C.O.). Heliospectra...

Spectrum Brands Holdings, Inc. (NYSE: SPB), a global consumer products company offering a broad portfolio of leading brands and focused on driving innovation and providing exceptional customer service, announced today it will release its fiscal 2019 fourth quarter and full year financial results for the period ended September 30, 2019 before the markets open on Wednesday, November 13. Spectrum Brands will conduct a live conference call and live webcast on November 13 at 9:00 a.m. Eastern Time...

Spectrum Therapeutics anuncia donativo en apoyo de las iniciativas de investigación y formación a cargo de la Canadian Sleep and Circadian Network PR Newswire SMITHS FALLS, ONTARIO y MONTREAL, 27 de septiembre de 2019 SMITHS FALLS, ONTARIO y MONTREAL, 27 de septiembre de 2019 /CNW/ - Spectrum Therapeutics ("Spectrum"), la división médica de Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), se complace en anunciar un donativo destinado a la Fondation de l'Hôpital du Sacré-Coeur de Montreal...

Spectrum Brands, Inc. Donates 10,000 Bottles of Insect Repellent to the American Red Cross After Hurricane Dorian PR Newswire ST. LOUIS, Sept. 26, 2019 ST. LOUIS , Sept. 26, 2019 /PRNewswire/ -- In the aftermath of Hurricane Dorian, Spectrum Brands, Inc., is donating 10,000 bottles of Cutter ® Insect Repellent products to the American Red Cross to help with the organization's ongoing disaster relief efforts. The supply of insect repellent will be used to restock American Red Cross warehouses...

Spectrum Therapeutics Announces Donation to Support Research and Education Initiatives Led by the Canadian Sleep and Circadian Network PR Newswire SMITHS FALLS, ON and MONTREAL, Sept. 26, 2019 SMITHS FALLS , ON and MONTREAL, Sept. 26, 2019 /PRNewswire/ - Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce a donation to the Fondation de l'Hôpital du Sacré-Coeur de Montreal (Montreal Sacre Coeur Hospital Foundation)...

Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today the early tender and consent results for its previously announced tender offer to purchase for cash by its wholly owned subsidiary, Spectrum Brands, Inc. (the “Company”), any and all of its outstanding 6.625% Senior Notes due 2022 (the "2022 Notes") and solicitation of consents to amend the indenture governing the 2022 Notes (the "Tender Offer and Consent...

SANTA MONICA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Automation Technology Expo (ATX) and Design & Manufacturing Minneapolis , the Midwest’s largest advanced design and manufacturing event, today announced its 2019 programming featuring a robust lineup of exhibitors leading the rapid growth of artificial intelligence (AI), automation, and robotics within the manufacturing industry, transforming the production process in the Midwest and globally. The two-day event will take place October 23...

Jefferies Financial Group Inc. (NYSE: JEF or Jefferies), which currently owns 7,514,477 shares, or approximately 15.4%, of the common stock of Spectrum Brands Holdings, Inc. (NYSE: SPB or Spectrum Brands), announced today that its Board of Directors has approved a distribution to stockholders of Jefferies of these Spectrum Brands shares. Jefferies will distribute the 7,514,477 Spectrum Brands shares through a special pro rata dividend (the “Distribution”) effective on October 11, 2019 (the...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today full pivotal Phase III study results for satralizumab as a monotherapy for neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disease. Results from the SAkuraStar study, presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), show that satralizumab monotherapy achieved a 55% reduction in the risk of relapses...

Spectrum Brands Holdings, Inc. (NYSE: SPB) announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) will sell $300.0 million aggregate principal amount of 5.00% Senior Notes due 2029 (the “Notes”) at a price of 100% of the par value (the “Offering”). The Notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to...

Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) commenced a cash tender offer (the “Tender Offer”) with respect to any and all of its $285 million aggregate outstanding principal amount of 6.625% Senior Notes due 2022 (the “Notes”). Concurrently with the Tender Offer, Spectrum Brands is soliciting from each holder of...

Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) has commenced an offering of $300 million in aggregate principal amount of Senior Notes due 2029 (the “Notes”). The terms of the proposed offering are subject to market conditions. The Notes will be offered only to persons reasonably believed to be qualified institutional...

Spectrum Brands Holdings, Inc. (NYSE: SPB), a global consumer products company offering a broad portfolio of leading brands and focused on driving innovation and providing exceptional customer service, announced today that Jeremy W. Smeltser, 44, will join the Company on October 1 as Executive Vice President. Mr. Smeltser will succeed Doug Martin, 57, as Executive Vice President and Chief Financial Officer on or prior to December 20, 2019. Mr. Smeltser will report to Chairman and Chief Executive...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data across its neuroscience portfolio will be presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) from September 11-13 in Stockholm. Presentations include complete Phase III results from the SAkuraStar study investigating satralizumab for the treatment of neuromyelitis optica spectrum disorder (NMOSD), and new multiple sclerosis (MS)...

Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress PR Newswire VANCOUVER, Sept. 3, 2019 Safety Outcomes of Interest Observed in Less Than 1% Cases; Zero Deaths Reported Greater Than 70% of Atrial Fibrillation Episodes Successfully Converted to Sinus Rhythm in a Median Time of 12 Minutes NASDAQ: CORV TSX: CORV VANCOUVER , Sept. 3, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company...

BOCA RATON, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. (Nasdaq: GNLN) (“Greenlane”), one of the largest global sellers of premium cannabis accessories, CBD and liquid nicotine products, today announced a partnership with Bouquet for exclusive U.S. distribution of its full spectrum CBD oil products, including tinctures and capsules offering a variety of strengths. Founded by Philadelphia investor, entrepreneur and philanthropist Max Tuttleman, Bouquet provides premium...